The pathogenesis of Listeria monocytogenes depends on its ability to attach to and invade the gastrointestinal epithelium and subsequently withstand the host immune response. Despite a thorough understanding of the intracellular phase of infection, relatively little is known about how the pathogen behaves in the gastrointestinal tract and whether it is affected by the presence of host commensal microbiota. Lactobacillus and Bifidobacterium are two important genera of the human gut microbiota proposed to possess probiotic effects. Here we demonstrate that probiotic bacteria significantly inhibit subsequent listerial infection in an in vitro C2Bbe1 epithelial cell model. In the case of Lactobacilli, inhibition was due to a combination of acid production and secretion of an as yet unidentified protein. In the case of Bifidobacterium, inhibition was attributable to an extracellular proteinaceous secreted compound. In addition, we observed a significant reduction in interleukin-8 and an increase in IL-10 cytokines secreted from epithelial cells following probiotic pretreatment and subsequent infection with Listeria. A reduction in the infection of epithelial cells and an altered mucosal immune response suggests that probiotic bacteria could be of therapeutic benefit against listerial infection. This study infers a role for probiotic bacteria as an antagonist of Li. monocytogenes infection.
Introduction
The gastrointestinal tract is a complex ecosystem which is likely to contain bacteria with both detrimental and beneficial effects on host physiology. Recently there has been significant research interest in the role of the gut microbiota in influencing the health status of the host. This research work is necessary to inform the deliberate use of bacterial supplements to manipulate the microbiota in a manner that could potentially assist in maintaining health and preventing disease (Holzapfel et al., 1998) . Probiotics (defined as any bacterium that when administered to human or animal hosts has health-promoting effects) could offer an alternative to conventional therapies such as antibiotics for the prophylaxis or treatment of intestinal infections (Bourlioux et al., 2003) . Lactobacillus and Bifidobacterium, members of the normal gastrointestinal microbiota, are among the most thoroughly characterized probiotic candidates and have been incorporated into many different foods, including fermented dairy products (Guerin-Danan et al., 1998) .
Lactobacillus spp. are the most widely used isolates in commercial probiotic products, with strains of Lactobacillus acidophilus and Lactobacillus casei strain Shirota being utilized due to their associated health benefits.
Probiotics are presumed to modulate the indigenous intestinal microbiota and improve health via multiple mechanisms of action, including the direct inhibition of enteric pathogens by decreasing luminal pH, the secretion of bactericidal proteins and the stimulation of defensin production by epithelial cells (Sartor, 2004) . They may also block pathogen attachment or invasion of epithelial cells by competing for surface receptors, a process termed colonization resistance (Salminen et al., 1996; Mack et al., 1999; Mattar et al., 2002) . In addition it has been shown that Lactobacillus plantarum and Lactobacillus rhamnosus inhibit adherence of enteropathogenic Escherichia coli to HT29 cells by inducing expression of the mucin genes, muc2 and muc3 (Mack et al., 2003) . Probiotic bacteria also improve epithelial and mucosal barrier function via release of short-chain fatty acids such as butyrate, a by-product of bacterial fermentation (Cook & Sellin, 1998) . Finally, probiotic bacteria have also been shown to alter host immune responses to infection by inducing expression of the anti-inflammatory cytokine interleukin-10 (IL-10), decreasing expression of pro-inflammatory interferon-g (IFN-g) and stimulating secretory IgA production (Fukushima et al., 1998; Silva et al., 2004; Di Giacinto et al., 2005) .
Listeria monocytogenes is a gram-positive food-borne pathogen that invades through the intestinal epithelium, causing the potentially fatal disease, listeriosis. Listeria monocytogenes is the fourth most common cause of meningeal infection, and it can also cause bacteraemia, septicaemia or a food-borne febrile gastroenteritis syndrome (Vázquez-Boland et al., 2001) . Listeria monocytogenes predominately affects pregnant, newborn and immunocompromised individuals, with a mortality rate of 20% or higher. In addition, Li. monocytogenes has long been used as a model organism for the study of intracellular parasitism and the associated immune response. Although much information is available regarding the infection of intestinal epithelial cells by Li. monocytogenes and subsequent systemic infection, little is known about how the bacterium interacts with the normal gut microbiota.
This study provides evidence that pretreating epithelial cells with strains of Bifidobacterium and Lactobacillus can significantly interfere with subsequent invasion by Li. monocytogenes, a process that is influenced by secreted products of probiotic bacterial cells. In addition, we demonstrate that the interaction between probiotic organisms and mucosal epithelial cells significantly impacts upon the subsequent host immune response.
Materials and methods

Bacterial strains, media and growth conditions
Listeria monocytogenes strains were grown in brain heart infusion broth (Oxoid) aerobically at 37 1C. Lactobacillus spp. were grown in MRS broth (Oxoid) for 36 h and then subcultured for a further 24 h. Lactobacillus salivarius strain UCC118 was grown aerobically at 37 1C. Lactobacillus acidophilus strain NCDO 1748 and La. casei strain NCDO 1205 were grown anaerobically at 37 1C. Lactococcus lactis strain NZ9000 was grown aerobically in GM17 broth at 30 1C overnight. Bifidobacterium spp. including Bifidobacterium breve UCC2003, Bifidobacterium infantis CCUG36569 and Bifidobacterium longum JCM7050 were grown in Reinforced Clostridial medium (RCM) for 36 h and then subcultured into MRS broth supplemented with cysteine-HCl for a further 24 h. All Bifidobacteria strains were incubated anaerobically at 37 1C.
C2Bbe1 cell culture conditions
C2Bbe1 cells, a clone of the Caco-2 human adenocarcinoma cell line, were used for in vitro assays (ATCC, CRC-2102) (Peterson & Mooseker, 1992 
Pretreatment of monolayers with probiotic bacteria and gentamycin infection assay
Monolayers were incubated with probiotic bacteria in antibiotic-free medium (1 mL total volume per well) at a concentration of 1 Â 10 8 CFU well À1 for 2 h (Fig. 1a) . This medium containing the probiotic bacteria was then removed, monolayers washed three times with 1 Â PBS and Li. monocytogenes was added at 1 Â 10 8 CFU well À1 in fresh antibiotic-free medium (1 mL total volume per well). Plates were incubated at 37 1C with 5% CO 2 for 1 h. Medium containing Li. monocytogenes was then replaced with 1 mL DMEM/10% FCS containing gentamycin at a concentration of 100 mg well À1 for 1 h. Monolayers were then washed three times with 1 mL 1 Â phosphate-buffered saline (PBS) and lysed with 100 mL ice-cold sterile dH 2 O. Serial dilutions were performed and plated onto brain heart infusion agar plates (Oxoid) to determine CFU per milliliter of invaded bacteria. Agar plates were incubated overnight at 37 1C. The gentamycin invasion assay was repeated with La. casei NCDO1205 using differentiated C2Bbe1 monolayers to determine whether a probiotic pretreatment could still protect against listerial infection of differentiated monolayers (Fig. 1b) . Differentiated epithelial cells display features of differentiated intestinal cells, including expression of a brush border (Peterson & Mooseker, 1992) .
Pretreatment of monolayers with probiotic bacteria contained in impermeable chambers
To determine if an active soluble compound caused the effect on listerial invasion, impermeable millicell chambers (Millipore, pore size 0.4 mm) were used (Fig. 2a) . The millicell chambers were placed in each well of the tissue culture plate while C2Bbe1 cells were seeded at the bottom of tissue culture plate wells; thus, probiotic bacteria were separated from epithelial monolayers. Probiotic bacteria were added to the impermeable millicell chambers in 500 mL DMEM at a concentration of 1 Â 10 8 CFU per millicell chamber and plates were incubated for 2 h. Millicell chambers containing probiotic bacteria were removed, epithelial monolayers were washed three times with 1 Â PBS and Li. monocytogenes was added at 1 Â 10 8 CFU well
À1
in fresh antibiotic-free medium (1 mL total volume per well). Tissue culture plates were then incubated for a further 1 h. The gentamycin infection assay was then performed.
Pretreatment of monolayers with probiotic supernatants
To determine the nature of the active soluble compound, overnight cultures of bacteria were centrifuged (5000 g for 10 min) and cell-free supernatants obtained. Supernatants were either untreated ($pH 4-5), neutralized to pH 7 with NaOH, or treated with trypsin for 30 min to degrade proteins ( Fig. 2b-d) . Then, 250-mL volumes of supernatants were added to tissue culture wells (1 mL total volume of media per well) and incubated for 2 h at 37 1C in 5% CO 2 . Following incubation, media containing the probiotic supernatants were removed, monolayers were washed three times with 1 mL 1 Â PBS and Li. monocytogenes was added at 1 Â 10 8 CFU well À1 in fresh antibioticfree medium (1 mL total volume per well). Plates were then incubated at 37 1C with 5% CO 2 for 1 h. Following incubation, the gentamycin treatments were performed as described above and CFU per milliliter of Li. monocytogenes which invaded epithelial monolayers was determined. The assay was repeated using pretreatment of monolayers with 250 mL MRS broth, trypsin or culture media at pH 7 to exclude any effect of these treatments on invasion by Listeria (Fig. 2e) .
Stimulation of C2Bbe1 monolayers and enzymelinked immunosorbent assay (ELISA) measurement of cytokine production
To determine if prior exposure of C2Bbe1 monolayers to probiotic bacteria influences the mucosal immune response to Li. monocytogenes, monolayers were incubated with probiotic bacteria at a concentration of 1 Â 10 8 CFU well
À1
(1 mL total volume DMEM per well) for 2 h ( Fig. 3a and b ). Monolayers were then washed three times with 1 mL 1 Â PBS and Li. monocytogenes was added at 1 Â 10 8 CFU well
in fresh antibiotic-free medium (1 mL total volume per well). Plates were then incubated at 37 1C with 5% CO 2 for 8 h. Following incubation, supernatants were collected and centrifuged at 13 000 g for 8 min, transferred to clean microcentrifuge tubes and stored at À 80 1C until analysis of cytokines using Duoset ELISA Development kits (R&D Systems). This assay was repeated using initial inoculums of 1 Â 10 8 and 1 Â 10 7 CFU well À1 Li. monocytogenes EGDe so as to control for intracellular numbers present after probiotic pretreatment, due to the observed 1log reduction in Listeria invasion following probiotic pretreatments (Fig.  3c ). For human IL-8 and IL-10 measurement, highest standards used were 2000 and 3000 pg mL À1 , respectively.
Kit protocols were followed and plates were analysed using SOFTPRO-MAX software. Cytokine analysis was also performed on supernatants stimulated with probiotic bacteria alone as a control. 
Statistical analysis
Results
Probiotic bacteria interfere with invasion of Li. monocytogenes EGDe in human epithelial monolayers
The gentamycin invasion assay was used to assess the invasion efficiency of Li. monocytogenes EGDe into the human coloncarcinoma Caco-2 epithelial cell clone, C2Bbe1, with and without pretreatment with probiotic bacteria (Fig. 1a) . Strains of Lactobacilli and Bifidobacteria were used, while a strain of Lactococcus lactis was also included as a control nonprobiotic strain (insofar as any organism can be said to be unlikely to be a probiotic, lactococci are not normal members of the human gut microbiota and do not survive well in the gastrointestinal tract). Approximately 3 Â 10 6 -3 Â 10 7 CFU mL À1 Listeria invaded untreated monolayers. Listeria monocytogenes showed significantly decreased infection of epithelial monolayers following pre-exposure of epithelial monolayers to all bacteria, with reductions of between 60% and 90% in relative invasion efficiency (Fig. 1a) . While in this assay system Lactococcus performed as well as the probiotic strains, it should be noted that this organism is highly unlikely to reach the epithelium in vivo in high numbers or in a viable state. Differentiated epithelial cells display features of differentiated intestinal cells, including expression of a brush border (Peterson & Mooseker, 1992) . However, there was no difference observed between undifferentiated and differentiated C2Bbe1 monolayers on inhibition of Li. monocytogenes invasion following pretreatment with La. casei NCDO1205 (Fig. 1b) . For this reason, undifferentiated C2Bbe1 monolayers were used for the remainder of the experiments.
Involvement of a secreted soluble component
To investigate the mode of protection further, gentamycin infection assays were performed in which the probiotic bacteria were separated from epithelial monolayers by an impermeable membrane during pretreatment (Fig. 2a) . The millicell chambers containing probiotics were then removed, the monolayers washed and Li. monocytogenes EGDe added directly to the wells containing epithelial monolayers. All probiotic bacteria except Lactococcus lactis strain NZ9000 were capable of inhibiting Li. monocytogenes invasion (Fig.  2a) , essentially to the same extent as in the assays performed without separation (Fig. 1a) . Therefore, we concluded that interference with listerial infection does not solely rely on direct physical contact with the epithelial monolayer but involves a secreted soluble component. As Lactococcus lactis strain NZ9000 was unable to cause inhibition when separated from the enterocytes, we concluded that it does not secrete an active component affecting Li. monocytogenes invasion.
To determine if the inhibitory effect was due to the reduction in pH associated with the growth of the probiotic bacteria, gentamycin infection assays were performed after pretreatment of epithelial monolayers with cell-free supernatants ($pH 4-5) and neutralized supernatants (Fig. 2b  and c) . Inhibition of invasion was observed with the bifidobacterial supernatants; however, in the case of Lactobacilli, neutralizing the supernatants eliminated this interference ( Fig. 2b and c) . This might initially suggest that inhibition by Lactobacilli is due to acid, but proteinasetreated supernatants (at pH 4) also had no effect on invasion (Fig. 2d) . As a control for an acid effect on invasion, monolayers were pretreated with culture media at pH 7, but this did not interfere with the ability of Li. monocytogenes to invade epithelial cells (Fig. 2e) . This suggests that interference with infection by Lactobacilli was due to a secreted proteinaceous molecule active at the low pH of the probiotic supernatant. In the case of the Bifidobacteria, neutralized supernatants still provided significant inhibition of listerial invasion, while trypsinized supernatants lost this interference ( Fig. 2c and d) . Thus, in the case of Bifidobacteria, the observed inhibitory effect appears to be due to a secreted protein factor and not due to low pH. Pretreatment of monolayers with MRS broth (pH 4-5), trypsin or culture media at pH 7 did not affect the ability of Li. monocytogenes EGDe to invade epithelial monolayers (Fig. 2e) .
Probiotic bacteria alter the host mucosal immune response to listerial infection
Assays were performed to assess the host response to the different probiotic bacteria used in this study (Fig. 3a and  b) . Treatment of C2Bbe1 monolayers with all probiotic strains for 2 h before stimulation with Li. monocytogenes EGDe for a further 8 h significantly reduced proinflammatory IL-8 and increased anti-inflammatory IL-10 production ( Fig. 3a and b) . There was no detectable IL-8 or IL-10 following stimulation of monolayers with probiotic bacteria only or in monolayers without bacterial treatment (Fig. 3a  and b) . Infection of monolayers with 1 Â 10 8 and 1 Â 10 7 CFU well À1 Li. monocytogenes EGDe was performed as a control for intracellular numbers of Li. monocytogenes and there was no difference in level of cytokine secreted in either case (Fig. 3c ). These results demonstrate that probiotic bacteria can modulate the immune response to listerial infection.
Discussion
This study demonstrates that a variety of probiotic commensal organisms can significantly inhibit Li. monocytogenes infection in vitro. Protection of the host gastrointestinal tract from invading pathogens is an important role postulated for probiotic bacteria. Previous studies have shown that probiotic bacteria can inhibit the ability of pathogenic bacteria to interact with intestinal epithelial cells (Bernet et al., 1993; Mack et al., 1999; Resta-Lenert & Barrett, 2003; Sgouras et al., 2004; Tsai et al., 2004) . The probiotic E. coli strain Nissle 1917 was shown to interfere with the invasion of intestinal INT407 cells by Salmonella enterica serovar Typhimurium, Yersinia enterocolitica, Shigella flexneri, Legionella pneumophilia and Li. monocytogenes (Altenhoefer et al., 2004) . Lactobacillus casei DN-114 001 inhibits adherence and invasion of intestinal epithelial cells by pathogenic adherent-invasive E. coli (AIEC), a bacterium found to colonize ileal lesions in some Crohn's patients (Ingrassia et al., 2005) . While probiotic bacteria have been found to have beneficial effects on the outcome of certain infections, this has never been specifically investigated in the case of Li. monocytogenes. The present study examined the ability of different probiotic bacteria to inhibit listerial infection of enterocytes, an important step in Listeria pathogenesis (Vázquez-Boland et al., 2001) . In this study, we showed that pretreatment of intestinal epithelial cells with probiotic bacteria prior to infection with Li. monocytogenes EGDe resulted in a significant decrease in listerial invasion (60-90%). It is important to note that probiotic bacteria or bacterial supernatants were only in contact with the epithelial monolayer and never came into contact with Listeria. Furthermore, when probiotic bacteria were separated from epithelial monolayers by impermeable Millicell chambers, the anti-invasive activity remained. Thus, this anti-invasive activity is independent of direct physical contact with both the intestinal monolayer and Li. monocytogenes. Therefore, for all strains, physical blocking of epithelial surface receptors was not the primary mechanism of action. In addition, Lactococcus lactis NZ9000 did not inhibit Listeria invasion when separated from the enterocytes, confirming that not all bacterial strains have this ability. Upon further characterization of this effect, probiotic bacteria were shown to inhibit invasion through secretion of a proteinaceous compound. In the case of the Lactobacilli, this compound (or compounds) was active at low pH. In the case of the Bifidobacteria, inhibition was not due to an acid effect but rather a secreted proteinaceous factor.
Our work supports previous studies of probiotic inhibition of other pathogens. Strains of Lactobacillus and Bifidobacterium have been shown to impede infection of human intestinal cell lines by E. coli and cell-free culture supernatants from probiotic bacteria significantly reduced numbers of culturable E. coli and the invasiveness of this strain (Gopal et al., 2001 ). This inhibitory action was proposed to be due to a synergistic action of lactic acid and proteinaceous substances. Furthermore, Lactobacilli have been shown to have multifactorial inhibition against Salmonella in vitro ( Fayol-Messaoudi et al., 2005) . Similarly, we also observed pH and nonacid-dependent activities of Lactobacilli against Listeria infection of intestinal epithelial cells. Future work in our laboratory is aimed at identification of the exact nature of these secreted proteins and their role in reducing infection.
In this study, the observed probiotic effect is mediated via interaction of the secreted component with the epithelial monolayer, and not via interaction with the invading Listeria. A possible mechanism for this effect may include enhancement of epithelial barrier function through induction of mucin secretion and maintenance of tight junctions and cytoskeletal integrity (O'Hara & Shanahan, 2007) . Probiotics have been found to enhance expression of transmembrane and tight junction proteins, resulting in improved barrier function and reduced bacterial translocation (Qin et al., 2005; Shen et al., 2006) . Studies have shown that probiotic bacteria can inhibit invasion by pathogenic bacteria through induction of mucin expression, thereby blocking bacterial attachment to intestinal cells (Mack et al., 1999 (Mack et al., , 2003 Mattar et al., 2002) . Further analysis is currently ongoing in our laboratory to determine whether probiotic bacteria inhibit listerial infection in vitro via mucin overexpression or enhanced barrier integrity.
The cell culture model of infection used in this analysis is a robust and tractable in vitro model that provides for initial analysis of host-microbe interactions in a controlled environment. We recognize that the true in vivo environment is clearly more complex. It is apparent that commensal bacteria in situ are located primarily in the lumen of the gastrointestinal tract whilst the mucous overlying epithelial cells, particularly in the villous crypts, contains relatively few microorganisms (Muller et al., 2005) . However, both local inflammation and immune sampling of commensal organisms are likely to increase direct contact between the microbiota and host epithelia (Muller et al., 2005; O'Hara & Shanahan, 2007) and would potentially elicit the effects demonstrated in the current study. In addition, by separating commensal bacteria from epithelial cells using Millipore chambers, we clearly demonstrate that direct contact between bacteria and the monolayer is not necessary to influence listerial invasion.
Finally, we have shown that pretreatment of C2Bbe1 monolayers with Lactobacilli or Bifidobacteria significantly reduces the amount of proinflammatory IL-8 produced in response to listerial infection. Pretreatment of monolayers also significantly increased the anti-inflammatory cytokine IL-10 following infection by Li. monocytogenes. This shows that probiotic commensal organisms may regulate the local immune response to Li. monocytogenes infection in the gastrointestinal tract. In the present study, Bifidobacteria and Lactobacilli alone do not induce production of either IL-8 or IL-10 cytokines from epithelial cells. This demonstrates that epithelial cells respond differently to various bacterial species, with the intestinal epithelium remaining immunologically quiescent upon encountering probiotic commensal bacteria (Kelly et al., 2005; O'Hara et al., 2006) . Probiotics have been shown to play a role in the development of disease by altering the host mucosal immune response to infection (O'Mahony et al., 2001; Menard et al., 2004) . In a previous study, B. infantis and La. salivarius failed to induce IL-8 secretion from epithelial cells but modulated the immune response to S. typhimurium (O'Hara et al., 2006) . Bifidobacterium breve and Streptococcus thermophilus secrete metabolites which inhibit lipopolysaccharide-induced TNF-á secretion from peripheral blood mononuclear cell (PBMC) monolayers (Menard et al., 2004) . Lactobacillus salivarius ssp. salivarius UCC118 has been shown to reduce tumour development in IL-10-knockout mice (O'Mahony et al., 2001) , while the probiotic mixture, VSL#3, when administered to mice with Th-1-mediated colitis, induced antiinflammatory cytokine IL-10, thus reducing inflammation and mortality (Di Giacinto et al., 2005) . This may be an important consideration in the treatment of chronic inflammatory conditions of the gastrointestinal tract that may be influenced by local immune responses (Krammer et al., 2005) . Possible mechanisms by which probiotic bacteria alter the host immune response to infection include attenuation of NFkB activation via Toll-like receptor signalling or inhibition of IkB-a ubiquitination, and thus altered expression of target genes (Neish et al., 2000; Kelly et al., 2005; O'Hara et al., 2006; Riedel et al., 2006) .
In conclusion, this study demonstrates that probiotic bacteria may have potential for the prophylaxis or treatment of listeriosis. The results of the invasion experiments clearly show the ability of probiotics to impede invasion by Li. monocytogenes significantly. The secreted component (or components) that prevents listerial invasion of intestinal epithelial cells warrants further investigation. Work is in progress to determine whether this anti-invasive activity is due to overexpression of mucin or whether other mechanisms may be involved. Future work using microarray studies examining the global cellular response to Li. monocytogenes infection will consider the influence of the indigenous microbiota upon the host response to infection.
